Patient Assistance Programs
Eligible patients who need help paying for their Bristol-Myers Squibb medicines may get assistance through a number of programs.
Bristol-Myers Squibb
Patient Assistance Foundation
more details |
- Varies by program
- Financial hardship
- Patient must live in the U.S., Puerto Rico or the U.S. Virgin Islands
|
Includes 12 medicines
|
800-736-0003
www.bmspaf.org |
Destination Access
more details |
- Varies by product
- Patient must live in the U.S., Puerto Rico or the U.S. Virgin Islands
|
ERBITUX® (cetuximab)
IXEMPRA™(ixabepilone)
SPRYCEL® (dasatinib)
|
800-861-0048
Destination Access
|
Access Virology
more details |
- Financial hardship
- Patient must live in the U.S., Puerto Rico or the U.S. Virgin Islands
- No prescription drug coverage
|
BARACLUDE® (entecavir)
REYATAZ® (atazanavir sulfate)
SUSTIVA® (efavirenz) |
888-281-8981
Download an
application |
ATRIPLA Patient Assistance Program
more details |
- Temporary assistance for those in need
|
ATRIPLA® (efavirenz / emtricitabine / tenofovir disoproxil fumarate)
|
866-290-4767
Download an application
|
The ORENCIA® (abatacept) Promise Program™
|
- Temporary copay assistance program for patients who have private insurance and are new to ORENCIA.
- Other restrictions and exclusions may apply.
|
ORENCIA® (abatacept)
|
800-ORENCIA
(800-673-6242)
www.orencia.com |
Together Rx Access
more details
|
- Low income
- Medicare recipients are not eligible
- No prescription drug coverage
- Legal resident of U.S.
|
Savings on nine medicines
|
800-444-4106
TogetherRxAccess.com
|
The Partnership for Prescription Assistance
more details
|
- No prescription drug coverage
- Financial hardship
|
Access to more than 475 patient assistance programs covering 2,500 prescription medicines, including 18 Bristol-Myers Squibb brands
|
888-4PPA-NOW
(888-477-2669)
www.pparx.org |
Please click on the product links to see the full prescribing information including Boxed WARNINGS for ABILIFY®, ATRIPLA®, BARACLUDE®, ERBITUX®, and Boxed WARNINGS for AVAPRO® and AVALIDE® regarding use in pregnancy. As soon as pregnancy is detected, discontinue use of AVAPRO® or AVALIDE®.
Click here for trademark information on Bristol-Myers Squibb products.